Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-02-18 Sale |
2025-02-19 8:11 pm |
Seres Therapeutics Inc. | MCRB | Young Teresa L. See Remarks |
3,338 | $0.8102 | $2,704 | 142,223 (Direct) |
View |
| 2025-02-18 Sale |
2025-02-19 8:10 pm |
Seres Therapeutics Inc. | MCRB | Henn Matthew R. See Remarks |
3,953 | $0.8104 | $3,204 | 130,380 (Direct) |
View |
| 2025-02-18 Sale |
2025-02-19 8:08 pm |
Seres Therapeutics Inc. | MCRB | Shaff Eric D. CEO and President |
12,726 | $0.8105 | $10,314 | 334,226 (Direct) |
View |
| 2025-02-18 Sale |
2025-02-19 8:07 pm |
Seres Therapeutics Inc. | MCRB | DesRosier Thomas Chief Legal Officer and EVP |
4,300 | $0.8105 | $3,485 | 190,424 (Direct) |
View |
| 2025-02-18 Sale |
2025-02-19 8:05 pm |
Seres Therapeutics Inc. | MCRB | von Moltke Lisa See Remarks |
4,416 | $0.8105 | $3,579 | 90,343 (Direct) |
View |
| 2024-11-18 Sale |
2024-11-19 4:21 pm |
Seres Therapeutics Inc. | MCRB | DesRosier Thomas Chief Legal Officer and EVP |
878 | $0.5407 | $475 | 159,099 (Direct) |
View |
| 2024-11-18 Sale |
2024-11-19 4:20 pm |
Seres Therapeutics Inc. | MCRB | von Moltke Lisa See Remarks |
977 | $0.5407 | $528 | 59,134 (Direct) |
View |
| 2024-11-18 Sale |
2024-11-19 4:15 pm |
Seres Therapeutics Inc. | MCRB | Young Teresa L. See Remarks |
735 | $0.541 | $398 | 114,311 (Direct) |
View |
| 2024-11-18 Sale |
2024-11-19 4:15 pm |
Seres Therapeutics Inc. | MCRB | Shaff Eric D. CEO and President |
2,505 | $0.5409 | $1,355 | 240,702 (Direct) |
View |
| 2024-11-18 Sale |
2024-11-19 4:15 pm |
Seres Therapeutics Inc. | MCRB | Henn Matthew R. See Remarks |
927 | $0.5407 | $501 | 103,083 (Direct) |
View |
| 2024-10-28 Sale |
2024-10-29 6:33 pm |
Seres Therapeutics Inc. | MCRB | von Moltke Lisa See Remarks |
4,334 | $0.6902 | $2,991 | 30,423 (Direct) |
View |
| 2024-10-28 Sale |
2024-10-29 6:27 pm |
Seres Therapeutics Inc. | MCRB | Henn Matthew R. See Remarks |
3,984 | $0.6901 | $2,749 | 75,885 (Direct) |
View |
| 2024-10-28 Sale |
2024-10-29 6:26 pm |
Seres Therapeutics Inc. | MCRB | DesRosier Thomas Chief Legal Officer and EVP |
4,259 | $0.6901 | $2,939 | 133,414 (Direct) |
View |
| 2024-10-28 Sale |
2024-10-29 6:24 pm |
Seres Therapeutics Inc. | MCRB | Shaff Eric D. CEO and President |
8,748 | $0.6901 | $6,037 | 165,082 (Direct) |
View |
| 2024-10-28 Sale |
2024-10-29 6:23 pm |
Seres Therapeutics Inc. | MCRB | Young Teresa L. See Remarks |
2,983 | $0.6901 | $2,059 | 88,483 (Direct) |
View |
| 2024-08-16 Sale |
2024-08-19 5:48 pm |
Seres Therapeutics Inc. | MCRB | DesRosier Thomas Chief Legal Officer and EVP |
873 | $0.84 | $733 | 150,736 (Direct) |
View |
| 2024-08-16 Sale |
2024-08-19 5:45 pm |
Seres Therapeutics Inc. | MCRB | von Moltke Lisa See Remarks |
973 | $0.84 | $817 | 50,701 (Direct) |
View |
| 2024-08-16 Sale |
2024-08-19 5:42 pm |
Seres Therapeutics Inc. | MCRB | Henn Matthew R. See Remarks |
923 | $0.84 | $775 | 95,372 (Direct) |
View |
| 2024-08-16 Sale |
2024-08-19 5:38 pm |
Seres Therapeutics Inc. | MCRB | Shaff Eric D. CEO and President |
2,518 | $0.84 | $2,115 | 224,118 (Direct) |
View |
| 2024-08-16 Sale |
2024-08-19 5:36 pm |
Seres Therapeutics Inc. | MCRB | Young Teresa L. See Remarks |
728 | $0.84 | $612 | 106,669 (Direct) |
View |
| 2024-08-16 Sale |
2024-08-19 5:29 pm |
Seres Therapeutics Inc. | MCRB | Ege David S. See Remarks |
1,128 | $0.84 | $948 | 107,263 (Direct) |
View |
| 2024-08-05 Sale |
2024-08-06 4:15 pm |
Seres Therapeutics Inc. | MCRB | Young Teresa L. See Remarks |
24,480 | $1.0839 | $26,534 | 78,178 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-04-10 Option Award |
2025-04-11 4:05 pm |
N/A 2035-04-09 |
Seres Therapeutics Inc. | MCRB | Biondi Paul Director |
100,000 | $0 | 100,000 (Direct) |
View |
| 2025-04-10 Option Award |
2025-04-11 4:05 pm |
N/A 2035-04-09 |
Seres Therapeutics Inc. | MCRB | Fraser Claire Director |
100,000 | $0 | 100,000 (Direct) |
View |
| 2025-04-10 Option Award |
2025-04-11 4:05 pm |
N/A 2035-04-09 |
Seres Therapeutics Inc. | MCRB | Graves Kurt Director |
100,000 | $0 | 100,000 (Direct) |
View |
| 2025-04-10 Option Award |
2025-04-11 4:05 pm |
N/A 2035-04-09 |
Seres Therapeutics Inc. | MCRB | Berenson Stephen Director |
100,000 | $0 | 100,000 (Direct) |
View |
| 2025-04-10 Option Award |
2025-04-11 4:05 pm |
N/A 2035-04-09 |
Seres Therapeutics Inc. | MCRB | Kender Richard N Director |
100,000 | $0 | 100,000 (Direct) |
View |
| 2025-04-10 Option Award |
2025-04-11 4:05 pm |
N/A 2035-04-09 |
Seres Therapeutics Inc. | MCRB | Ausiello Dennis A Director |
100,000 | $0 | 100,000 (Direct) |
View |
| 2025-04-10 Option Award |
2025-04-11 4:05 pm |
N/A 2035-04-09 |
Seres Therapeutics Inc. | MCRB | Dere Willard H Director |
100,000 | $0 | 100,000 (Direct) |
View |
| 2025-02-15 Exercise |
2025-02-19 8:11 pm |
N/A N/A |
Seres Therapeutics Inc. | MCRB | Young Teresa L. See Remarks |
10,470 | $0 | 142,223 (Direct) |
View |
| 2025-02-15 Exercise |
2025-02-19 8:10 pm |
N/A N/A |
Seres Therapeutics Inc. | MCRB | Henn Matthew R. See Remarks |
10,626 | $0 | 130,380 (Direct) |
View |
| 2025-02-15 Exercise |
2025-02-19 8:08 pm |
N/A N/A |
Seres Therapeutics Inc. | MCRB | Shaff Eric D. CEO and President |
34,376 | $0 | 334,226 (Direct) |
View |
| 2025-02-15 Exercise |
2025-02-19 8:07 pm |
N/A N/A |
Seres Therapeutics Inc. | MCRB | DesRosier Thomas Chief Legal Officer and EVP |
11,564 | $0 | 190,424 (Direct) |
View |
| 2025-02-15 Exercise |
2025-02-19 8:05 pm |
N/A N/A |
Seres Therapeutics Inc. | MCRB | von Moltke Lisa See Remarks |
11,876 | $0 | 90,343 (Direct) |
View |
| 2025-02-07 Option Award |
2025-02-11 4:15 pm |
N/A 2035-02-06 |
Seres Therapeutics Inc. | MCRB | Thorell Marella See Remarks |
650,000 | $0 | 650,000 (Direct) |
View |
| 2025-02-07 Option Award |
2025-02-11 4:15 pm |
N/A 2035-02-06 |
Seres Therapeutics Inc. | MCRB | Young Teresa L. See Remarks |
650,000 | $0 | 650,000 (Direct) |
View |
| 2025-02-07 Option Award |
2025-02-11 4:15 pm |
N/A 2035-02-06 |
Seres Therapeutics Inc. | MCRB | Henn Matthew R. See Remarks |
650,000 | $0 | 650,000 (Direct) |
View |
| 2025-02-07 Option Award |
2025-02-11 4:15 pm |
N/A 2035-02-06 |
Seres Therapeutics Inc. | MCRB | Shaff Eric D. CEO and President |
1,950,000 | $0 | 1,950,000 (Direct) |
View |
| 2025-02-07 Option Award |
2025-02-11 4:15 pm |
N/A 2035-02-06 |
Seres Therapeutics Inc. | MCRB | von Moltke Lisa See Remarks |
650,000 | $0 | 650,000 (Direct) |
View |
| 2025-02-07 Option Award |
2025-02-11 4:15 pm |
N/A 2035-02-06 |
Seres Therapeutics Inc. | MCRB | DesRosier Thomas Chief Legal Officer and EVP |
650,000 | $0 | 650,000 (Direct) |
View |
| 2025-02-04 Option Award |
2025-02-06 08:05 am |
N/A 2035-02-03 |
Seres Therapeutics Inc. | MCRB | Woerle Hans-Juergen Director |
120,000 | $0 | 120,000 (Direct) |
View |
| 2024-11-15 Exercise |
2024-11-19 4:21 pm |
N/A N/A |
Seres Therapeutics Inc. | MCRB | DesRosier Thomas Chief Legal Officer and EVP |
2,656 | $0 | 159,099 (Direct) |
View |
| 2024-11-15 Exercise |
2024-11-19 4:20 pm |
N/A N/A |
Seres Therapeutics Inc. | MCRB | von Moltke Lisa See Remarks |
2,969 | $0 | 59,134 (Direct) |
View |
| 2024-11-15 Exercise |
2024-11-19 4:15 pm |
N/A N/A |
Seres Therapeutics Inc. | MCRB | Young Teresa L. See Remarks |
2,656 | $0 | 114,311 (Direct) |
View |
| 2024-11-15 Exercise |
2024-11-19 4:15 pm |
N/A N/A |
Seres Therapeutics Inc. | MCRB | Shaff Eric D. CEO and President |
7,812 | $0 | 240,702 (Direct) |
View |
| 2024-11-15 Exercise |
2024-11-19 4:15 pm |
N/A N/A |
Seres Therapeutics Inc. | MCRB | Henn Matthew R. See Remarks |
2,812 | $0 | 103,083 (Direct) |
View |
| 2024-10-27 Exercise |
2024-10-29 6:33 pm |
N/A N/A |
Seres Therapeutics Inc. | MCRB | von Moltke Lisa See Remarks |
13,744 | $0 | 30,423 (Direct) |
View |
| 2024-10-27 Exercise |
2024-10-29 6:27 pm |
N/A N/A |
Seres Therapeutics Inc. | MCRB | Henn Matthew R. See Remarks |
12,622 | $0 | 75,885 (Direct) |
View |
| 2024-10-27 Exercise |
2024-10-29 6:26 pm |
N/A N/A |
Seres Therapeutics Inc. | MCRB | DesRosier Thomas Chief Legal Officer and EVP |
13,500 | $0 | 133,414 (Direct) |
View |
| 2024-10-27 Exercise |
2024-10-29 6:24 pm |
N/A N/A |
Seres Therapeutics Inc. | MCRB | Shaff Eric D. CEO and President |
27,837 | $0 | 165,082 (Direct) |
View |
| 2024-10-27 Exercise |
2024-10-29 6:23 pm |
N/A N/A |
Seres Therapeutics Inc. | MCRB | Young Teresa L. See Remarks |
11,360 | $0 | 88,483 (Direct) |
View |
Ownership |
2024-10-02 08:15 am |
N/A N/A |
Seres Therapeutics Inc. | MCRB | NESTLE SA Societe des Produits Nestle S.A. 10% Owner |
0 | $0 | 21,879,753 (Indirect) |
View |
| 2024-08-15 Exercise |
2024-08-19 5:48 pm |
N/A N/A |
Seres Therapeutics Inc. | MCRB | DesRosier Thomas Chief Legal Officer and EVP |
2,656 | $0 | 150,736 (Direct) |
View |
| 2024-08-15 Exercise |
2024-08-19 5:45 pm |
N/A N/A |
Seres Therapeutics Inc. | MCRB | von Moltke Lisa See Remarks |
2,969 | $0 | 50,701 (Direct) |
View |
| 2024-08-15 Exercise |
2024-08-19 5:42 pm |
N/A N/A |
Seres Therapeutics Inc. | MCRB | Henn Matthew R. See Remarks |
2,813 | $0 | 95,372 (Direct) |
View |
| 2024-08-15 Exercise |
2024-08-19 5:38 pm |
N/A N/A |
Seres Therapeutics Inc. | MCRB | Shaff Eric D. CEO and President |
7,813 | $0 | 224,118 (Direct) |
View |
| 2024-08-15 Exercise |
2024-08-19 5:36 pm |
N/A N/A |
Seres Therapeutics Inc. | MCRB | Young Teresa L. See Remarks |
2,656 | $0 | 106,669 (Direct) |
View |
| 2024-08-15 Exercise |
2024-08-19 5:29 pm |
N/A N/A |
Seres Therapeutics Inc. | MCRB | Ege David S. See Remarks |
2,969 | $0 | 107,263 (Direct) |
View |
| 2024-08-03 Exercise |
2024-08-06 4:15 pm |
N/A N/A |
Seres Therapeutics Inc. | MCRB | Young Teresa L. See Remarks |
85,000 | $0 | 78,178 (Direct) |
View |
| 2024-07-01 Option Award |
2024-07-03 4:15 pm |
N/A 2034-06-30 |
Seres Therapeutics Inc. | MCRB | Ausiello Dennis A Director |
64,564 | $0 | 64,564 (Direct) |
View |
| 2024-07-01 Option Award |
2024-07-03 4:15 pm |
N/A 2034-06-30 |
Seres Therapeutics Inc. | MCRB | Graves Kurt Director |
64,564 | $0 | 64,564 (Direct) |
View |